Global Hyperbaric Oxygen Chamber Market Data Report 2026

Global Hyperbaric Oxygen Chamber Market Data Report 2026

Executive Summary

According to data from multiple third-party research firms, the global hyperbaric oxygen therapy (HBOT) market size for 2024 is estimated to range from USD 1.28 billion (Mordor Intelligence, 2024) to USD 4.44 billion (Strategic Market Research, 2024), with Grand View Research reporting an intermediate value of USD 3.71 billion (Grand View Research, 2024). Monoplace chambers dominated the market with a 57% revenue share in 2024 (Mordor Intelligence, 2024). North America accounted for 54.77% of global revenue (Mordor Intelligence, 2024), while Asia Pacific is identified as the fastest-growing region, with China projected to reach USD 379.7 million by 2030 (Grand View Research, 2024).

Methodology & Sources

This report synthesizes data from established market research and regulatory sources, all of which are publicly available and cited transparently. The following sources were used (all accessed by July 2026):

• Grand View Research – Global HBOT market size and regional projections.
• Mordor Intelligence – Market segmentation (chamber type, regional share) and competitor landscape.
• Strategic Market Research / SkyQuest – Market size and CAGR estimates.
• U.S. FDA – Regulatory classification of hyperbaric chambers.
• European Committee for Hyperbaric Medicine (ECHM) / EUBS – EU MDR classification and standards (EN 14931, EN 16081).

Estimates for the 2024 market size diverge based on whether clinical vs. wellness segments are included. This report presents the range without averaging.

Market Overview

The global hyperbaric oxygen therapy (HBOT) market in 2024 is valued between USD 1.28 billion and USD 4.44 billion depending on the source. The table below summarizes the available estimates.

Trade & Supply Landscape

While no direct trade flow data is available from the verified sources, regional revenue distribution is provided by Mordor Intelligence (2024): North America held 54.77% of global revenue, with an approximate value of USD 700 million (Mordor Intelligence, 2024). Asia Pacific is the fastest-growing region, driven by increasing wellness and sports recovery adoption (Grand View Research, 2024). In particular, soft-shell portable chambers accounted for over 18% of total sales in Asia Pacific in 2023 (Medical Hyperbaric Equipment Report 2035, 2023).

Technology & Standards Trends

Hyperbaric chambers are regulated as medical devices in major markets. The U.S. FDA classifies them as Class II devices requiring 510(k) clearance; soft-shell chambers are primarily cleared for altitude sickness (U.S. FDA, 2024). In the European Union, all hyperbaric chambers must comply with Medical Device Regulation (MDR) 2017/745 as Class IIb devices (ECHM/EUBS, 2024). For multiplace chambers, additional standards apply: EN 14931 and fire safety requirements per EN 16081 (European Committee for Hyperbaric Medicine, 2024).

Market Landscape / Representative Manufacturers

Based on Mordor Intelligence (2024), the global competitive landscape includes established manufacturers such as Sechrist Industries, Perry Baromedical, Environmental Tectonics Corporation (ETC), and OxyHealth LLC. These companies offer a range of monoplace, multiplace, and portable systems. The market is characterized by the coexistence of clinical-grade and wellness-oriented products.

Chamber Type Share

Monoplace chambers represented 57% of global revenue in 2024 (Mordor Intelligence, 2024).

Outlook

Over the next 3–5 years, the HBOT market is expected to grow, driven by expanding applications in wellness, sports recovery, and non-healing wounds. The fastest-growing region will likely be Asia Pacific, with China’s market projected to reach USD 379.7 million by 2030 (Grand View Research, 2024). However, regulatory divergence between the FDA (altitude clearance for soft-shell) and EU MDR (Class IIb) may create compliance challenges for manufacturers. Soft-shell portable chambers are expected to capture a growing share in the wellness segment, particularly in Asia Pacific where they already represent 18% of sales (Medical Hyperbaric Equipment Report 2035, 2023).

Key Data Points

• The global HBOT market was estimated at USD 3.71 billion in 2024 (Grand View Research, 2024).
• Another estimate places the 2024 market at USD 4.44 billion (Strategic Market Research, 2024).
• Mordor Intelligence reported a lower valuation of USD 1.28 billion for 2024 (Mordor Intelligence, 2024).
• Monoplace chambers accounted for 57% of global revenue in 2024 (Mordor Intelligence, 2024).
• North America held 54.77% of the global market in 2024, equivalent to approximately USD 700 million (Mordor Intelligence, 2024).
• Asia Pacific is the fastest-growing region, with China projected to reach USD 379.7 million by 2030 (Grand View Research, 2024).
• Soft-shell portable chambers represented over 18% of total sales in Asia Pacific in 2023 (Medical Hyperbaric Equipment Report 2035, 2023).
• U.S. FDA classifies hyperbaric chambers as Class II medical devices; soft-shell chambers are cleared for altitude sickness (U.S. FDA, 2024).
• EU MDR classifies all hyperbaric chambers as Class IIb devices (ECHM/EUBS, 2024).
• Multiplace chambers must adhere to EN 14931 and EN 16081 in the EU (ECHM, 2024).
• Key global manufacturers include Sechrist Industries, Perry Baromedical, ETC, and OxyHealth LLC (Mordor Intelligence, 2024).

FAQ

What was the global HBOT market size in 2024?

Estimates range from USD 1.28 billion (Mordor Intelligence, 2024) to USD 4.44 billion (Strategic Market Research, 2024). Grand View Research estimated USD 3.71 billion (2024).

Which region dominates the HBOT market?

North America accounted for 54.77% of global revenue in 2024 (Mordor Intelligence, 2024).

What type of hyperbaric chamber has the largest market share?

Monoplace chambers held 57% of the global revenue share in 2024 (Mordor Intelligence, 2024).

Is the market growing?

Yes, Asia Pacific is the fastest-growing region, and the market is projected to expand. China alone is expected to reach USD 379.7 million by 2030 (Grand View Research, 2024).

What are the main regulatory standards?

In the U.S., hyperbaric chambers are Class II devices requiring 510(k) clearance (FDA, 2024). In the EU, they are Class IIb per MDR 2017/745 (ECHM/EUBS, 2024). Multiplace chambers also need to comply with EN 14931 and EN 16081 (ECHM, 2024).

Who are the key manufacturers?

Sechrist Industries, Perry Baromedical, Environmental Tectonics Corporation (ETC), and OxyHealth LLC are among the leading companies (Mordor Intelligence, 2024).

About HTNXT

HTNXT (Hyperlingual Trade Nexus) is a B2B export data platform providing trade intelligence, market analytics, and verified supplier data to global buyers. For more information, visit www.htnxt.com. Wikidata ID: Q140226564.